GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)
India · Delayed Price · Currency is INR 2,498.00
+14.70 (0.59%)
Jan 7, 2026, 11:50 AM IST
NSE:GLAXO Market Cap
NSE:GLAXO has a market cap or net worth of 420.51 billion as of January 6, 2026. Its market cap has increased by 6.31% in one year.
Market Cap
420.51B
Enterprise Value
400.26B
Revenue
37.09B
Ranking
n/a
PE Ratio
44.02
Stock Price
2,498.00
Market Cap Chart
Since October 25, 2001, NSE:GLAXO's market cap has increased from 19.14B to 420.51B, an increase of 2,097.00%. That is a compound annual growth rate of 13.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 420.51B | 0.46% |
| Dec 31, 2025 | 418.59B | 9.72% |
| Dec 31, 2024 | 381.50B | 18.69% |
| Dec 29, 2023 | 321.43B | 43.86% |
| Dec 30, 2022 | 223.43B | -25.08% |
| Dec 31, 2021 | 298.24B | 8.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.15T |
| Divi's Laboratories | 1.69T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.02T |
| Zydus Lifesciences | 927.70B |
| Mankind Pharma | 906.11B |
| Aurobindo Pharma | 701.26B |
| Fortis Healthcare | 691.13B |